Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tema Cardiovascular and Metabolic ETF (HRTS)

Tema Cardiovascular and Metabolic ETF (HRTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Tema ETFs
  • Assets Under Management 80,352,000
  • Shares Outstanding, K 2,480
  • 60-Month Beta N/A
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.75%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.20 +7.32%
on 11/19/24
34.58 -6.28%
on 11/11/24
-0.79 (-2.38%)
since 11/01/24
3-Month
30.20 +7.32%
on 11/19/24
35.53 -8.78%
on 09/19/24
-2.09 (-6.06%)
since 09/03/24
52-Week
27.10 +19.59%
on 12/11/23
36.03 -10.05%
on 07/16/24
+5.10 (+18.67%)
since 12/01/23

Most Recent Stories

More News
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 110.04 (+1.26%)
LLY : 812.33 (+1.57%)
HRTS : 32.41 (+0.03%)
PPH : 90.85 (+0.73%)
THNR : 24.25 (+0.92%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 110.04 (+1.26%)
LLY : 812.33 (+1.57%)
HRTS : 32.41 (+0.03%)
PPH : 90.85 (+0.73%)
THNR : 24.25 (+0.92%)
Tap the Weight-Loss Drug Market With These ETFs

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are...

RHHBY : 35.8700 (-0.58%)
NVO : 110.04 (+1.26%)
LLY : 812.33 (+1.57%)
HRTS : 32.41 (+0.03%)
THNR : 24.25 (+0.92%)
OZEM : 27.00 (+0.75%)
Not Sure Which Weight Loss Stock to Buy? Invest in This ETF

Many healthcare companies have been eagerly developing new weight loss drugs in an effort to cash in ...

LLY : 812.33 (+1.57%)
VKTX : 49.54 (-3.82%)
HRTS : 32.41 (+0.03%)
Don’t Know Which Weight-Loss Stock Will Be the Biggest Winner? Invest in This ETF Instead

There’s a lot of excitement in the weight-loss industry these days. Between Ozempic, Wegovy, Mounjaro, ...

HRTS : 32.41 (+0.03%)
LLY : 812.33 (+1.57%)
NVO : 110.04 (+1.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Fund Summary

The Tema Cardiovascular and Metabolic ETF seeks to provide long-term growth of capital by investing in companies leading the fight against diabetes, obesity and cardiovascular diseases.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 32.69
2nd Resistance Point 32.62
1st Resistance Point 32.51
Last Price 32.41
1st Support Level 32.33
2nd Support Level 32.26
3rd Support Level 32.15

See More

52-Week High 36.03
Fibonacci 61.8% 32.62
Last Price 32.41
Fibonacci 50% 31.56
Fibonacci 38.2% 30.51
52-Week Low 27.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar